Biomarkers Market - Discovery Technologies , Validation Services, Applications & Diseases - Global Trends & Forecasts (2013 - 2018)

DUBLIN, Feb. 7, 2014 PRNewswire/ --Research and Markets (http://www.researchandmarkets.com/research/bt6gxm/biomarkers_market) has announced the addition of the "Biomarkers Market - Discovery Technologies , Validation Services, Applications & Diseases - Global Trends & Forecasts (2013 - 2018)" report to their offering.

(Logo: http://photos.prnewswire.com/prnh/20130307/600769)

Biomarkers comprise definite cells, genes, molecules, gene products, enzymes, or hormones which are objectively measured as an indicator of typical biological processes, pathogenic processes, or pharmacologic response to a therapeutic intrusion. Major application areas of biomarkers are early disease diagnosis and prevention, drug target recognition, and drug discovery and development. The global market showcases high growth potential in the near future. This market is expected to grow at a CAGR of 18.5% from 2013 to 2018, to reach $40.8 billion by 2018.

The global market has been segmented into biomarker discovery technologies, biomarker services, applications, and disease indications. The biomarker discovery technologies are classified as omics technology, imaging technology, and bioinformatics. Omics technology, which includes proteomics, genomics, transcriptomics, and metabolomics, accounts for the largest share of the biomarker discovery technology market. The biomarkers services market is classified into sample preparation, assay development, and biomarker validation and testing services. Biomarker applications market has been segmented as drug discovery and development, molecular diagnostics, and personalized medicine. Based on type of diseases, the biomarker disease indication market has been classified as oncology, cardiology, neurology, and other diseases (HIV, renal disorders, diabetes, arthritis, and tuberculosis).

Globally, the biomarkers market is witnessing a transformation and is expected to grow at a high growth rate in the coming years. The growth in the market will be primarily driven by advancements in discovery technologies, government initiatives and grants for biomarker research activities, and rising demand for personalized medicine. The incidence and prevalence of chronic diseases such as cancer, cardiac diseases, and diabetes is increasing globally and hence, it is crucial to develop new preventive and diagnostics treatments. Since, biomarkers play a significant role in development of preventive and diagnostic tests and drugs, the demand of biomarkers is expected to increase rapidly.

Over the past few years, the biomarkers industry has been witnessing increasing number of contracts and partnership agreements among market players for the development of novel biomarkers. Major research on biomarkers is taking place in the field of oncology. Recent developments of companies such as Thermo Fisher Scientific, Inc. (U.S.), QIAGEN N.V. (Netherlands), Roche Diagnostics (Switzerland), Hologic, Inc. (U.S.), and Johnson & Johnson (U.S.) have exhibited inclination towards agreements and partnerships, in accordance to their key strategy to expand their market share and geographical presence.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Overview

4 Global Biomarkers Market, By Discovery Technologies

5 Services Market Of Biomarkers

6 Biomarkers Application Market

7 Biomarkers Indication Market

8 Geographical Analysis

9 Competitive Landscape

10 Company Profiles

Companies Mentioned:

• Abbott Laboratories
• Abcodia Ltd
• Affymetrix Inc
• Agilent Technologies Inc
• Amgen Inc
• Astrazeneca Plc
• Augurex Life Sciences Corp
• Aushon Biosystems Inc
• BGI
• Bayer Ag
• Beckman Coulter Inc
• Biocrates Life Sciences AG
• Biomarkers Strategies
• Biosystems International
• Bristol-Myers Squibb
• Caprion Proteomics Inc
• Crescendo Bioscience
• Eisai Co Ltd
• Epiontis GMBH
• Epistem Holdings PLC
• Eurogentec SA
• Evotec AG
• Glaxosmithkline PLC
• Ipsen
• Johnson & Johnson
• Merck & Co
• Micromedic Technologies Ltd
• Myriad Genetics Inc
• Nextgen Sciences Inc
• Novartis International AG
• Ocimum Biosolutions Ltd
• Pacific Biomarkers Inc
• Pfizer Inc
• Pronota NV
• Proteome Sciences Plc
• Qiagen Nv
• Quintiles Transnational Corporation
• Roche Diagnostics Limited
• Sanofi-Aventis
• Siemens Healthcare
• Trans-Hit Biomarkers Inc
• Vermillion Inc

For more information visit http://www.researchandmarkets.com/research/bt6gxm/biomarkers_market

Media Contact: Laura Wood , +353-1-481-1716, press@researchandmarkets.net